Clinical Trials in third countries: EU plans ethics review at marketing authorisation phase
This article was originally published in SRA
Executive Summary
Vibha Sharma reports from a European Medicines Agency workshop on the monitoring of ethics and GCP considerations when conducting clinical trials in third countries.